Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.54 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.54 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.54 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.54 |
| ▸ | PYGM | P11217 | 3/20 | 0.45 |
| ▸ | CDK1 | P06493 | 1/20 | 0.44 |
| ▸ | CDA | P32320 | 2/20 | 0.42 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.42 |
| ▸ | TK2 | O00142 | 2/20 | 0.42 |
| ▸ | PNP | P00491 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20895 | 1.00 | SLC28A1 (0.54) | SLC28A1SLC28A2SLC29A1SLC28A3PYGM | |
| Phosphoric Acid SCHEMBL3514477 | 0.95 | SLC28A1 (0.50) | SLC28A1SLC28A2SLC29A1SLC28A3PYGM | |
| Phosphoric Acid SCHEMBL21890 | 0.95 | SLC28A1 (0.50) | SLC28A1SLC28A2SLC29A1SLC28A3PYGM | |
| Orotic Acid SCHEMBL8148333 | 0.91 | SLC28A1 (0.46) | SLC28A1SLC28A2SLC29A1SLC28A3PYGM | |
| SCHEMBL29410228 | 0.90 | SLC28A1 (0.43) | SLC28A1SLC28A2SLC29A1SLC28A3PYGM | |
| SCHEMBL11126488 | 0.89 | SLC28A1 (0.53) | SLC28A1SLC28A2SLC29A1SLC28A3PYGM | |
| SCHEMBL11126479 | 0.89 | SLC28A1 (0.53) | SLC28A1SLC28A2SLC29A1SLC28A3PYGM | |
| SCHEMBL31065334 | 0.88 | SLC28A1 (0.52) | SLC28A1SLC28A2SLC29A1SLC28A3PYGM | |
| Ornithine Aketoglutarate SCHEMBL29240459 | 0.87 | SLC28A1 (0.43) | SLC28A1SLC28A2SLC29A1SLC28A3PYGM | |
| Aconitic Acid SCHEMBL29444992 | 0.87 | SLC28A1 (0.43) | SLC28A1SLC28A2SLC29A1SLC28A3PYGM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1718 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680258-A1 | BACILLUS AMYLOLIQUEFACIENS STRAINS ART12 AND ART24 FOR THE TREATMENT OF DISORDERS OF THE CNS | Artugen Therapeutics Ltd. (IE) | 2026-01-21 | — | — | EP | claimed |
| CN-117427088-B | Equivalent component group of Angong bezoar bolus for improving ischemic cerebral apoplexy injury and application thereof | 中国药科大学 | 2025-05-09 | — | — | CN | claimed |
| CN-119950533-A | Application of oroxylin A in preparation of antihypertensive drugs | 福建中医药大学 | 2025-05-09 | — | — | CN | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| CN-119432702-A | Uracil producing strain, construction method and application thereof | 新疆瑞诺生物科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| WO-2024254556-A9 | BACTERIAL COMPOSITIONS FOR METABOLIZING UREMIC TOXINS | ATOSSA THERAPEUTICS, INC. (US) | 2025-01-30 | — | — | WO | claimed |
| WO-2024254556-A1 | BACTERIAL COMPOSITIONS FOR METABOLIZING UREMIC TOXINS | ATOSSA THERAPEUTICS, INC. (US) | 2024-12-12 | — | — | WO | claimed |
| EP-4457514-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE | Société des Produits Nestlé S.A. (CH) | 2024-11-06 | — | — | EP | claimed |
| CN-118620816-B | Uridine producing strain, construction method and application thereof | 天津科技大学 | 2024-10-29 | — | — | CN | claimed |
| WO-2024194737-A1 | BACILLUS AMYLOLIQUEFACIENS STRAINS ART12 AND ART24 FOR THE TREATMENT OF DISORDERS OF THE CNS | ARTUGEN THERAPEUTICS LTD. (IE) | 2024-09-26 | — | — | WO | claimed |
| EP-0870841-A1 | PROCESSES FOR PRODUCING SUGAR NUCLEOTIDES AND COMPLEX CARBOHYDRATES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1998-10-14 | — | — | EP | claimed |
| EP-0861902-A1 | PROCESSES FOR PRODUCING SUGAR NUCLEOTIDES AND COMPLEX CARBOHYDRATES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1998-09-02 | — | — | EP | claimed |
| EP-0551394-A1 | TRICHODERMA REESEI CONTAINING DELETED AND/OR ENRICHED CELLULASE AND OTHER ENZYME GENES AND CELLULASE COMPOSITIONS DERIVED THEREFROM | GENENCOR INTERNATIONAL, INC. (US) | 1993-07-21 | — | — | EP | claimed |
| WO-1992006209-A1 | TRICHODERMA REESEI CONTAINING DELETED AND/OR ENRICHED CELLULASE AND OTHER ENZYME GENES AND CELLULASE COMPOSITIONS DERIVED THEREFROM | GENENCOR INTERNATIONAL INC. (US) | 1992-04-16 | — | — | WO | claimed |
| US-4968606-A | FERMENTATION OF MICROORGANISMS WITH OROTIDINE OR OROTIDIC ACID, INORGANIC PHOSPHATE AND 1,2,4-TRIAZOLE-3-CARBOXAMIDE IN WATER | AJINOMOTO CO., INC. (JP) | 1990-11-06 | — | — | US | claimed |
| EP-0122151-B1 | PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1989-02-15 | — | — | EP | claimed |
| US-4783402-A | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1988-11-08 | — | — | US | claimed |
| US-4577012-A | ABSORPTION ON ACTIVATED CARBON, ELUTION WITH ALKALI HYDROXIDE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1986-03-18 | — | — | US | claimed |
| EP-0149775-A1 | Compositions of nucleic acid components | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1985-07-31 | — | — | EP | claimed |
| EP-0122151-A2 | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1984-10-17 | — | — | EP | claimed |